Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2011 1
2012 1
2013 1
2015 1
2020 5
2021 1
2022 1
2024 1
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.
Dagogo-Jack S, Kazemi EJ, Doherty L, Srikanthan P, Echouffo-Tcheugui JB, Knowler WC, Kahn SE, Mudaliar S, Temprosa M; DPP Research Group. Dagogo-Jack S, et al. Diabetes Care. 2025 Oct 1;48(10):1695-1703. doi: 10.2337/dc25-0633. Diabetes Care. 2025. PMID: 40882001 Free PMC article. Clinical Trial.
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes study.
Tjaden AH, Goldbaum AA, Edelstein SL, Heckman-Stoddard BM, Reedy J, Herman WH, Hoskin M, Knowler WC, Schlögl M, Temple KA, Venditti EM, Watson K, Temprosa M, Shams-White MM; DPP Research Group. Tjaden AH, et al. Am J Clin Nutr. 2025 Sep;122(3):715-723. doi: 10.1016/j.ajcnut.2025.07.011. Epub 2025 Jul 15. Am J Clin Nutr. 2025. PMID: 40675492 Clinical Trial.
Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study.
Walker EA, Gonzalez JS, Tripputi MT, Dagogo-Jack S, Matulik MJ, Montez MG, Tadros S, Edelstein SL; DPP Research Group. Walker EA, et al. BMJ Open Diabetes Res Care. 2020 Oct;8(1):e001537. doi: 10.1136/bmjdrc-2020-001537. BMJ Open Diabetes Res Care. 2020. PMID: 33023898 Free PMC article. Clinical Trial.
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program.
Heckman-Stoddard BM, Crandall JP, Edelstein SL, Prorok PC, Dabelea D, Hamman R, Hazuda HP, Horton E, Hoskin MA, Perloff M, Bowers A, Knowler WC, Ford LG, Temprosa M; DPP Research Group. Heckman-Stoddard BM, et al. Cancer Prev Res (Phila). 2025 Jul 1;18(7):401-411. doi: 10.1158/1940-6207.CAPR-23-0461. Cancer Prev Res (Phila). 2025. PMID: 40243198 Clinical Trial.
Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program.
Aroda VR, Christophi CA, Edelstein SL, Perreault L, Kim C, Golden SH, Horton E, Mather KJ; DPP Research Group. Aroda VR, et al. BMJ Open Diabetes Res Care. 2020 Dec;8(2):e001841. doi: 10.1136/bmjdrc-2020-001841. BMJ Open Diabetes Res Care. 2020. PMID: 33328161 Free PMC article. Clinical Trial.
The Diabetes Prevention Program: recruitment methods and results.
Rubin RR, Fujimoto WY, Marrero DG, Brenneman T, Charleston JB, Edelstein SL, Fisher EB, Jordan R, Knowler WC, Lichterman LC, Prince M, Rowe PM; DPP Research Group. Rubin RR, et al. Control Clin Trials. 2002 Apr;23(2):157-71. doi: 10.1016/s0197-2456(01)00184-2. Control Clin Trials. 2002. PMID: 11943442 Clinical Trial.
17 results